Constan


Indications and Reactions:

Role Indications Reactions
Secondary
Insomnia 26.7%
Depression 20.6%
Suicide Attempt 13.0%
Epilepsy 7.3%
Dysthymic Disorder 5.3%
Intentional Overdose 4.9%
Drug Use For Unknown Indication 3.6%
Pyrexia 3.6%
Anxiety 1.6%
Panic Disorder 1.6%
Systemic Lupus Erythematosus 1.6%
Affective Disorder 1.2%
Constipation 1.2%
Gastritis 1.2%
Gastritis Prophylaxis 1.2%
Hypertension 1.2%
Product Used For Unknown Indication 1.2%
Schizophrenia 1.2%
Analgesic Therapy 0.8%
Antipyresis 0.8%
White Blood Cell Count Increased 17.1%
Stevens-johnson Syndrome 12.2%
Vomiting 12.2%
Sepsis 9.8%
Rash Generalised 7.3%
Somnolence 4.9%
Urinary Retention 4.9%
Urine Output Decreased 4.9%
Aspartate Aminotransferase Increased 2.4%
Blood Creatine Phosphokinase Increased 2.4%
Completed Suicide 2.4%
Eosinophil Count Increased 2.4%
Metrorrhagia 2.4%
Nasopharyngitis 2.4%
Renal Tubular Disorder 2.4%
Respiratory Depression 2.4%
Road Traffic Accident 2.4%
Status Epilepticus 2.4%
Tremor 2.4%
Concomitant
Insomnia 12.3%
Depression 10.2%
Hypertension 10.0%
Drug Use For Unknown Indication 9.0%
Pustular Psoriasis 7.6%
Chronic Hepatitis C 6.4%
Anxiety 5.5%
Prophylaxis 5.4%
Parkinson's Disease 5.1%
Constipation 3.6%
Pain 3.2%
Diabetes Mellitus 2.8%
Osteoporosis 2.8%
Panic Disorder 2.6%
Gastrointestinal Disorder 2.4%
Anxiety Disorder 2.3%
Eating Disorder 2.3%
Prophylaxis Against Gastrointestinal Ulcer 2.3%
Hyperlipidaemia 2.1%
T-cell Type Acute Leukaemia 2.1%
White Blood Cell Count Decreased 15.0%
Vomiting 9.7%
Staphylococcal Infection 7.1%
Tremor 7.1%
Hepatic Function Abnormal 5.3%
Suicidal Ideation 5.3%
Ventricular Tachycardia 5.3%
Inappropriate Antidiuretic Hormone Secretion 4.4%
Sudden Onset Of Sleep 4.4%
Weight Decreased 4.4%
Liver Disorder 3.5%
Malaise 3.5%
Platelet Count Decreased 3.5%
Rash 3.5%
Suicide Attempt 3.5%
Xeroderma 3.5%
Cardiogenic Shock 2.7%
Colitis Ulcerative 2.7%
Drug Withdrawal Syndrome Neonatal 2.7%
Herpes Zoster 2.7%

Drug Data